Emergent BioSolutions EBS
NYSE EBS
$6.09 -0.01 (-0.16%)
As of: Nov 10, 2026 · 12:43 PM EST

Emergent BioSolutions (EBS) Total Debt (2010 - 2026)

Updated

Emergent BioSolutions (EBS) reported Total Debt of $507.7 million for Q3 2026, down 23.4% from $663.1 million a year earlier and down 12.7% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Total Debt (2010 - 2026) Analysis & Trends

At the end of FY2025, Emergent BioSolutions posted Total Debt of $572.1 million, down 13.8% from FY2024.

  • Total Debt has declined for three consecutive years, with a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
  • By year, Total Debt came in at $663.7 million in FY2024 (-22.8%), $860.2 million in FY2023 (-38.8%), $1.41 billion in FY2022 (+67.2%) and $841 million in FY2021 (-3.9%).
  • The Q3 2026 figure ranks as the lowest quarterly Total Debt since Q3 2018.
  • Year over year, Total Debt has now declined in each of the last four quarters, with an average decline of 17.0% over the last eight quarters.
  • The high point for year-over-year Total Debt in five years was Q1 2023 (growth of 67.9%); the low point was Q4 2023 (a decline of 38.8%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $581.8 million (Q2 2026), $573.6 million (Q1 2026) and $572.1 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 44.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 80.90 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 32.35 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 26.23 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 62.67 Bn
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn 507.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 507.70 Mn
Jun 30, 2026 581.80 Mn
Mar 31, 2026 573.60 Mn
Dec 31, 2025 572.10 Mn
Sep 30, 2025 663.10 Mn
Jun 30, 2025 667.80 Mn
Mar 31, 2025 665.70 Mn
Dec 31, 2024 663.70 Mn
Sep 30, 2024 662.60 Mn
Jun 30, 2024 862.20 Mn
Mar 31, 2024 905.90 Mn
Dec 31, 2023 860.20 Mn
Sep 30, 2023 861.80 Mn
Jun 30, 2023 903.20 Mn
Mar 31, 2023 1.40 Bn
Dec 31, 2022 1.41 Bn
Sep 30, 2022 1.05 Bn
Jun 30, 2022 825.20 Mn
Mar 31, 2022 833.10 Mn
Dec 31, 2021 841.00 Mn
API Access

Emergent BioSolutions Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=EBS&period=max&api_key=YOUR_API_KEY